This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
LEXINGTON, Mass., July 2, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the JMP Securities 8
th Annual Healthcare Conference, which will be held at the St. Regis New York. Dr. Garo Armen, Chairman and CEO of Agenus, will present a corporate overview on Tuesday, July 9
th at 12:30 pm ET.
Web Cast Information
The live and archived webcast of the company presentation will be accessible from the company's website at
www.agenusbio.com/webcast . Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Agenus website for one month following the conference.
Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. For more information, please visit
CONTACT: Media and Investor Contact:
Jonae R. Barnes
Investor Relations and